HAS-BLED is the standard bedside score for estimating major bleeding risk in patients who take or are about to start anticoagulants for atrial fibrillation. Nine yes or no questions produce a score from zero to nine. Scores of three or more flag patients who need closer monitoring and correction of modifiable risk factors rather than automatic withdrawal of treatment.
Your visual report appears here
Fill in the form and press Calculate. You will get your number, an interpretation chip, and a personalized chart pack drawn instantly in your browser.
- Risk spectrum with your position marked
- Reference ranges from the original publication
- Shareable link, nothing stored
Scientific references
Every decision to prescribe a blood thinner weighs two competing dangers, the stroke the drug prevents and the bleeding it can cause. HAS-BLED was designed to put numbers on the second half of that equation. It appeared in 2010 from the Euro Heart Survey and was quickly adopted by European and international guidelines because its items are things a clinician already knows about the patient.
The Nine Letters
Hypertension that is not controlled earns one point. Abnormal kidney function and abnormal liver function count one point each, which is why the tool asks them separately. A previous stroke adds one, a bleeding history or a bleeding tendency such as anemia adds one, and an unstable INR in patients on warfarin adds another. Age above sixty five, drugs that promote bleeding such as aspirin or common painkillers, and regular heavy alcohol use complete the list at one point each.
What a High Score Means
A score of three or more marks high risk, with an annual major bleeding rate that climbs past four or five percent in the original cohorts. Crucially, guidelines stress that a high HAS-BLED score should not by itself stop anticoagulation. Most of its items can be improved, blood pressure can be controlled, interacting painkillers can be swapped, alcohol can be reduced, and warfarin patients with unstable INR can move to a modern direct anticoagulant.
Why Pair It With CHA2DS2-VASc
Stroke risk and bleeding risk share many ingredients, so patients with high CHA2DS2-VASc scores often also score high on HAS-BLED. Used together, the two scores frame the real conversation, the absolute stroke risk being prevented against the absolute bleeding risk being accepted, with modifiable items identified and addressed.
Regular reassessment matters because scores change as patients age, develop kidney problems, or start new medicines. A score calculated once at diagnosis is a snapshot, not a lifetime verdict.